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Although aliasing on color flow Doppler (CFD) has become a 
wide icator of disease, th s that it 
is a of CFD and prohibits of flows 
above the Nyquist limit. A Kontron Sigma-44 CFD unit with 
a two-frequency transmitter (QUASAR) can potentially 
elevate the maximum detectable velocity. We imaged tube 
and jet flows In vitro in order to evaluate the accuracy of 
the QUASAR system. Tube flows in a flow phantom with 
centerline velocities above the unshifted NyquisL limit 
were corrected to nonaliased displays. CFD orif ice 
velocities in turbulent jet (TJ) flows correlated well with 
actual values (Y-0.985X+0.048, r-0.99. SEE- 0.14 m/s), for 
velocities up to 3 m/s (non-QUASAR Nyquist - 0.6). 
Limitations: Because of the rapid velocity decay patterns 
characteristic of TJs, consistent centerline decay profiles 
could not be easily obtained in the QUASAR mode, as signal 
fall-out was commonly present. The expanded scale will 
require an increase in the number of color bins in order to 
place velocities in sufficiently small intervals for 
quantitation. 
Conclusions: The QUASAR concept is a critical step toward 
obtaining quantitative CFD data for the first time. The 
importance of obtaining such physically meaningful data is 
highlighted by recently reported assessment techniques 
which rely on a limitation of status quo CFD, namely, 
aliasing. 
EFFECT GF NALOXONE ON SYHPATHONEURAL AND HEMODYNAPPIC 
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In young hypertensive men (EX) is followed by a sustained 
reduction in BP and inhibition of central sympathetic 
outflow (SNA) . One proposed mechanism for these changes 
is that F.X activates central inhibitory opioid systems. To 
test this hypothesis we gave 9 young normai men high dose 
naloxone (N; 0.1 mg/kg, i.v.) or placebo (9) 30 min prior 
to EX on 2 separate days (double blind protocol). We 
recorded BP, HE, Doppler CO, calf blood flow (CBF), and 
resistances, muscle SNA (microneurography), plasma NE, and 
luteinizing hormone (LH) before and 60 min after 45 min of 
SUP (mmHg) 
HAP (Ml?ig) 
DBP (L;rHg) 6623 5723" 6623 61+3"'" 
HR (b/min) 59+4 69+4’“’ 6024 67+&**’ 
SNA(bursts/min) 2323 2324 24+2 29+5 
(bursts/100 hb) 3925 33+5 3923 4125 
PNE (nmol/L) 1.220.2 1.610.3 0.8kO.l 1.2+0.2" 
CBF(ml/min/LOO mL) 3.120.4 4.5kO.6 3.220.3 3.OkO.4 
CVR (Units) 3094 2726 2923 3024 
CO (L/min) 4.020.3 4.6+0.3""' 3.850.3 4.320.4" 
TPR (Units) 20.5k1.4 17.4+1.1”“* 21.452.2 20.622.8 
y<o’I;p 2.820.5 2.920.4 2.390.3 4.290.5'"" * . ““P<O . 01; “““PCO. 005 
Prior ekercise had modest effects on BP, attenuated by N. 
Higher values for PNE (P<O.O5 by P-way ANOW) and after 
EX on the N day are consistent with a central effect of M. 
However. vasodiletion was not associated with decreased 
SNA suggesting that peripheral exercise-endorphin inter- 
actions lower BP in normal subjects; central interactions 
may predominate if SNA is increased. 
